NAFLD (non-alcoholic fatty liver disease) is a common cause of chronic liver disease associated with the metabolic syndrome. Effective techniques are needed to investigate the potential of animal models of NAFLD. The present study aimed to characterize murine models of NAFLD by metabolic profiling of intact liver tissue. Mice of three strains (BALB/c, C3H and the novel mutant, Gena/263) were fed a control or high-fat diet. Biometric, biochemical and histological analysis demonstrated a spectrum of NAFLD from normal liver to steatohepatitis. Metabolic profiling of intact liver tissue, using 1 H MAS (proton magic angle spinning) MRS (magnetic resonance spectroscopy), showed an increase in the total lipid-to-water ratio, a decrease in polyunsaturation indices and a decrease in total choline with increasing disease severity. Principal components analysis and partial least-squares discriminant analysis showed separation of each model from its control and of each model from the total dataset. Class membership from the whole dataset was predicted with 100 % accuracy in six out of eight models. Those models with steatosis discriminated from those with steatohepatitis with 100 % accuracy. The separation of histologically defined steatohepatitis from simple steatosis is clinically important. Indices derived from 1 H MAS MRS studies may inform subsequent in vivo MRS studies at lower field strengths.
INTRODUCTION
NAFLD (non-alcoholic fatty liver disease) represents a spectrum of liver disease encompassing steatosis (fatty change), NASH (non-alcoholic steatohepatitis) and cirrhosis in the absence of alcohol abuse [1] . Population studies show that NAFLD is strongly associated with insulin resistance, Type 2 diabetes mellitus, hypertension, obesity and dyslipidaemia [2] [3] [4] . The pathogenic mechanisms remain poorly understood and are difficult to study in humans [5] . An estimated 10-24 % of adults worldwide have a degree of hepatic steatosis [6] , but only a small proportion of these go on to develop progressive disease, characterized histologically by steatohepatitis with fibrosis. In order to target therapy to the appropriate patients there is a need for accurate wellvalidated methods to analyse hepatic lipid content and metabolism.
MRS [MR (magnetic resonance) spectroscopy] provides information about the biochemical composition of tissues both in vivo and in vitro. In vivo, the technique has been used to assess the prevalence of NAFLD [7] ; recently, more detailed information on lipid composition has been reported [8] . In vitro, MRS has been applied to the study of liver tissue extracts in obese rats [9] , and urine and plasma from mice with features of NAFLD [10, 11] . In vitro 1 H MAS (proton magic angle spinning) MRS allows simultaneous analysis of lipid and aqueous compartments of intact solid tissue, resembling in vivo findings more closely than tissue extracts. In addition, 1 H MAS MRS requires a smaller mass of tissue for analysis compared with extracts [9, 12] , and enables histological evaluation of the sample following analysis [13] . 1 H MAS MRS has been applied to metabolic profiling in liver and other tissues from animal models and from humans [10, 12, [14] [15] [16] [17] .
Much of our understanding of the pathogenesis of NAFLD is based on research using animal models [1] . No existing model exhibits the entire NAFLD phenotype. Many differ pathologically from human disease in all but superficial histological appearance. Thus research is hampered by the lack of reliable models of progressive steatohepatitis that accurately reflect the human disease. Currently, the phenotyping of such models is reliant on physical observation, indirect biochemical assay and histopathology, all of which are time-consuming. In addition, subtle changes in metabolism and hepatic disease severity may not be detected using conventional techniques. Liver histology may be used to document overt features of NAFLD, such as the presence of hepatocellular lipid droplets, inflammation and fibrosis. Histological assessment is semi-quantitative and involves a degree of subjectivity in interpretation. There is a requirement for robust techniques to phenotype rapidly and categorize the output of programmes that develop new models of NAFLD. In particular, there is a need to identify animals which exhibit the characteristics of more advanced disease, including steatohepatitis. Accordingly, the aims of the present study were: (i) to characterize murine models of NAFLD using 1 H MAS MRS of intact liver tissue; (ii) to assess the predictive value of multivariate models to determine the strain and diet for each mouse on the basis of 1 H MAS MRS differences; and (iii) to compare MR spectral differences between histologically characterized normal liver, steatosis and steatohepatitis.
MATERIALS AND METHODS

Animals
The present study was approved by the local ethics committee and performed in accordance with the Animal (Scientific Procedures) Act 1986. Mice were housed under standard conditions (12 h light/dark cycle, temperature 21 + − 2
• C, humidity 55 + − 10 %) and were provided with food and access to drinking water ad libitum. Two inbred strains of mice, known to differ in susceptibility to dietary-induced NAFLD, C3H/HeH (sensitive) and BALB/cAnNCrl (resistant), were used in the present study (n = 6 for each group) [11] . In addition, a recently described genetic model of NASH maintained on a C3H/HeH background, Gena/263 'Buttermouse', was studied (n = 6-10 for each group) [18] . The Gena/263 model was identified using a phenotype-driven ENU (N-ethyl-N-nitrosourea) mutagenesis screen for impaired glucose tolerance and histological/biochemical evidence of steatohepatitis [18] . Male animals were randomized at 6 weeks of age to receive either CD (control diet) or a nutritionally replete HFD (highfat diet). The CD (SDS, Witham, U.K.) contained 4 % fat by weight (11.5 % of kcal) and the HFD (Research Diets, New Brunswick, U.S.A.) contained 24 % fat by weight (45 % of kcal). The composition of each diet is given in detail in Supplementary Table S1 (at http://www.clinsci.org/cs/116/cs1160403add.htm).
The mice remained on the allocated diet for the remainder of the study. Body weight was measured at ages 6, 20 and, where applicable, 36 weeks. Glucose tolerance was assessed using an IPGTT (intraperitoneal glucose tolerance test) at 12 weeks of age. Mice were culled by exsanguination under terminal anaesthesia at one of two time points, aged 20 or 36 weeks.
The liver was excised and half was snap-frozen in liquid nitrogen prior to storage at − 80
• C, while the remainder was placed in 10 % formalin. Formalin-fixed tissue was processed into paraffin wax and the sections were stained with haematoxylin and eosin, prior to histological examination by a histopathologist blinded to the phenotypic data, using the well-validated NASH Clinical Research Network semi-quantitative scoring system for cellular morphology, inflammation and fibrosis [19] .
MRS studies
Two samples were analysed from each liver (mean sample mass, 15.3 mg; S.D., 2.9 mg). Freshly thawed liver tissue was placed into XC4 Kel-F sealing cells (Doty Scientific).
1 H MAS MRS experiments were carried out using an MAS probe (Doty Scientific) interfaced with a JEOL Eclipse 500+ spectrometer and an 11.75 T superconducting magnet (Oxford Instruments). Samples were spun at 4000 Hz and kept at 4
• C to minimize sample degradation during data acquisition [15] . A pulse and collect sequence [TR (repetition time), 10 s; The residual water resonance at δ 4. 
Data analysis and interpretation
Spectra were processed using KnowItAll ® Informatics System v7.8 (Bio-Rad). Free induction decays were zerofilled by a factor of two and multiplied by an exponential windows function with a 1 Hz line-broadening function prior to Fourier transformation. Spectral resonances were assigned according to the published literature [12, [14] [15] [16] . Analysis was divided into hypothesisgenerating multivariate analysis and biologically relevant conventional analysis of specific metabolites. The spectral range of δ 0-10.0 p.p.m. was analysed, including the water region for the pulse and collect sequences and excluding the region containing the residual water resonance (δ 4.8-5.2 p.p.m.) in the sequences with water-presaturation. Spectra were scaled to the sum of the total spectral integral (water was included for sequences without water suppression and excluded for those with water presaturation) to enable relative quantificative analysis of metabolites between samples.
Multivariate data analysis
The 1 H MAS MR spectrum from intact liver tissue demonstrated numerous identifiable resonances or peaks corresponding to specific metabolites (see Figure 1) . Accordingly, multivariate data-reduction techniques were applied in order to use information from the whole spectrum, and to determine which peaks contributed to the metabolic variation between individual samples and between groups of samples.
MR spectra acquired using the pulse and collect sequence with water presaturation were divided into small regions ('buckets') of 0.04 + − 0.02 p.p.m., representing specific metabolite functional groups, placed using an 'intelligent bucketing' algorithm in the KnowItAll ® software. The integral of each bucket was then quantified and expressed as a proportion of the total spectral integral.
Unsupervised multivariate factor analysis was performed using PCA (principal components analysis) to assess clustering and the presence of outliers. PCA is an unbiased technique, which is independent of any classifying information (such as strain) and the output summarizes the metabolite variation within the dataset as a whole. Each principal component represents a combination of peaks, representing metabolites, expressed as a vector. The principal components are combined orthogonally, avoiding duplication or redundancy of information. Scores plots show the position of the samples in the newly defined multidimensional space, where the axes represent each orthogonal principal component. Examination of the loadings plots allows identification of those metabolites which predominantly account for variability within the dataset. Supervised analysis was performed using PLS-DA (partial least-squares discriminant analysis) to investigate factors associated with class membership, with the Pirouette v4.0 software package (Infometrics). In the present study, the classifying information is included in the analysis, so the output summarizes the MR spectral (metabolic) differences between the groups. OSC (orthogonal signal correction) is a filtering technique applied to PLS-DA to remove variation in the spectra, which is unrelated to the defined conditions [21] . To determine the predictive power of the model, cross-validation was performed by leaving out each sample in turn (a leave-one-out algorithm), and a model was constructed from the remaining samples to predict the class membership of the excluded sample. Such an algorithm makes best use of a small dataset, where a separate validation dataset is not possible. The Q 2 value indicates the validity of the discrimination, with values > 0.05 considered significant [22, 23] .
Examination of spectral resonances
In order to examine the specific differences between metabolite ratios of prior interest and those identified in the loading plots, peak integrals (proportional to the total quantity of the metabolite in the sample) were measured. The lipid/water ratio was derived from the pulse and collect spectra without water suppression, both as the sum of the integrals of all the fatty acid proton resonances and as the methylene proton/water peak expressed as a percentage. The PUFA (polyunsaturated fatty acid)/MUFA (mono-unsaturated fatty acid) index was derived from the pulse and collect spectra with water suppression, and comprised the resonance at δ 2.80 p.p.m. (defined as the diallylic bond protons found in PUFAs and denoted as 'PUFA') divided by the resonance at δ 5.33 p.p.m. (-CH = CH-functional group, found in MUFAs and PUFAs and denoted as 'MUFA'). The PUI (polyunsaturation index) was defined as the diallylic resonance divided by the sum of the allylic, diallylic, methyl and methylene resonances, expressed as a percentage [8] . tCho was derived from the pulse and collect spectra with water suppression and comprised the summed integral of the choline region resonances from δ 3.18-3.28 p.p.m., expressed as a percentage of the total spectral integral. The tCho region was analysed further using the CPMG data. Specifically, the resonance at δ 3.26 p.p.m., assigned as PtC (phosphatidylcholine) including contributions from betaine and TMAO (trimethylamine-N-oxide) and denoted as 'PtC', was compared with the tCho levels.
Significant differences in phenotypic data were sought by ANOVA testing with post-hoc Bonferroni-Dunn analysis. Significant differences in MR spectral data were identified by the Kruskal-Wallis test or the Mann-Whitney U test as appropriate (SPSS v14.0).
RESULTS
Phenotypic data
Body weight
At baseline there was no significant difference in body weight between the inbred strains; however, as shown in Table 1 , by 20 weeks there were significant differences in body weight both between the inbred strains and the dietary groups (measured by ANOVA, P < 0.001). CD-fed C3H mice gained weight more rapidly than CDfed BALB/c mice (35.32 + − 2.58 g compared with 26.49 + − 0.87 g; measured using a Student's t test, P = 0.006) and HFD-fed C3H mice gained the greatest weight, being significantly heavier than either CD-fed littermates (44.72 + − 0.34 g compared with 35.3 + − 2.57 g; P = 0.003) or HFD-fed BALB/c mice (27.52 + − 0.70 g; P < 0.001). Indeed HFD-fed BALB/c mice gained little weight and were not significantly heavier than CD-fed BALB/c mice.
These differences increased during the course of the study with HFD-fed C3H mice being significantly heavier than all other groups at the time of culling [55.24 + − 0.80 g compared with 43.31 + − 2.58 g for CD-fed C3H mice (P = 0.001) and 35.29 + − 1.11 g for HFD-fed BALB/c mice (P < 0.001)]. Although HFD-fed BALB/c mice began to increase in weight compared with controls, this did not reach statistical significance. Throughout the study, the weight of mutant Gena/263 mice was not significantly different to wild-type C3H mice fed the equivalent diet.
Glucose tolerance
ANOVA identified significant differences in blood glucose levels at all IPGTT time points (Table 1) . HFD-fed C3H mice had significantly higher mean t = 120 min blood glucose concentrations compared with HFD-fed BALB/c mice (11.86 + − 0.96 compared with 7.30 + − 1.80 mmol/l; measured using a Student's t test, P < 0.001). A trend towards impaired glucose tolerance was observed between HFD-and CD-fed C3H mice, but this did not reach statistical significance (11.86 + − 0.96 compared with 10.07 + − 0.41 mmol/l). HFDfed Gena/263 mutant mice had significantly higher t = 120 min blood sugar levels than all other groups (P < 0.001) including HFD-fed C3H mice (20.68 + − 0.53 compared with 11.86 + − 0.96 mmol/l). Values are means (S.E.M.) (for body weight and IPGTT) or medians (for histological score). Body weight was recorded at the start of the experiment (6 weeks of age), mid-experiment and at the point of culling. BALB/c and C3H were culled at 36 weeks, Gena/263 mice (and C3H controls) were culled at 20 weeks. NAS score: steatosis (0-3), fibrosis (0-4), inflammation (0-3), and ballooning hepatocyte degeneration (0-2). 
Histology
In keeping with the blunted weight gain and preservation of glucose tolerance in response to the HFD, BALB/c mice were highly resistant to dietary induction of steatosis, showing no histological evidence of steatosis in either CD or HFD groups at 36 weeks post-randomization. In contrast, HFD-fed C3H mice consistently exhibited a florid macro-and micro-vesicular steatosis (median steatosis score 2/3) associated with ballooning hepatocyte degeneration (median steatosis score 1/2) and a mild necro-inflammatory infiltrate (median steatosis score 1/3) ( Table 1) 
MR characterization
A representative water-suppressed 1 H MAS MR spectrum is shown in Figure 1 The sum of the integrals for all lipid peaks was compared with the integral of the methylene lipid peak in all samples, demonstrating a strong correlation between measures (Spearman Rho correlation, r = 0.998, P < 0.0005). Accordingly, the integral of the methylene proton resonance was considered a surrogate for total lipid when describing lipid quantities relative to water.
PCA scores plots (results not shown) demonstrated clustering and separation of each mouse model from its control. This included the separation of models on the basis of diet (CD or HFD), strain (BALB/c and C3H, both CD-fed and HFD-fed) and also the presence of the Gena/263 mutation from the wild-type control, both CD-fed and HFD-fed.
Supervised PLS-DA models were then constructed. Correct class prediction was achieved with 100 % accuracy for six out of seven comparisons of differing diet, strain and presence of the 263 mutation (Table 2) .
Metabolites contributing to the spectral regions correlating strongly (positively or negatively) with each model compared with its control are shown in Table 3 . Lipid moieties, choline-related compounds, glucose, glycogen and a number of amino acid resonances (including glutamine, leucine, lysine and alanine) were found to contribute to class separation. In particular, PtC (with contributions from betaine and TMAO) was found to be a major contributor to the PLS-DA models. Accordingly, PtC was integrated using the CPMG spectra and divided by the tCho region for comparison with histological class. The use of tCho as a denominator allowed relative quantification of PtC without the potentially confounding dilutional effect of large changes in total lipid.
Table 2 A comparison of each model against its control
PLS-DA models were constructed to separate the MR spectra obtained from a given mouse model from its control as specified, with one orthogonal factor removed (OSC). In addition to the separation of each model from its control, PLS-DA models were constructed to enable the classification of a single sample from the total dataset. In all, 54 samples were included in the total dataset and class membership was established with 100 % accuracy in six out of eight model (Table 4) .
Comparison between 1 H MAS MRS and histological assessment
The distinction between simple steatosis and steatohepatitis is of importance for the development of models which reflect progressive disease in humans. Therefore PCA was performed on spectra from mice of all strains fed an HFD and stratified by histological assessment of NAFLD. The samples were divided into histologically normal, steatotic and steatohepatitic groups on the basis of histological assessment of an adjacent slice of tissue (Figure 2) . Steatohepatitis was defined in the present study as the presence of hepatocyte ballooning with/without the presence of necro-inflammatory infiltrate. All samples in the steatohepatitis group had evidence of hepatocyte ballooning. PCA demonstrated clustering of the groups, so PLS-DA was performed to assess the factors associated with category membership. Category membership (between histologically normal, steatotic and steatohepatitic 
steatosis (C, C and D) and steatohepatitis (E, E and F)
The 'total signal' MR spectra (A, C and E) illustrate the ratio of water to other metabolites. The 'lipid signal' MR spectra (A , C and E ) amplify other major metabolite groups. The lipid consituents increase, while the tCho decreases, with increasing disease severity. Characteristic histological features of steatosis (lipid droplets) and steatohepatitis (hepatocyte ballooning) from the corresponding tissue sample are shown in (D) and (F).
samples) using the leave-one-out algorithm was predicted with very high accuracy, as shown in Table 5 .
The intrahepatic lipid level (median, interquartile range) differed significantly between samples histologically categorized as normal (1.96 %, 1.02), steatotic (8.09 %, 3.71) and steatohepatitic (10.56 %, 6.08) (Figure 3A) . There was a significant decrease in the PUFA/ MUFA index between the normal (0.68, 0.09) and either steatotic (0.37, 0.12) or steatohepatitic (0.32, 0.09) samples. The PUFA/MUFA index did not differentiate between the steatotic and steatohepatitic groups ( Figure 3B ). The PUI was decreased in steatotic (3.40 %, 0.95) and steatohepatitic mice (2.95 %, 1.13) compared with normal mice (6.29 %, 1.25) (measured using a Mann-Whitney U test, P < 0.001). Therefore the increase in the PUFA/MUFA index can be interpreted as consequent to a systematic decrease in PUFA with increasing disease severity. The resonances at (PC and GPC) were found consistently to contribute to the difference between mouse classes on multivariate statistical modelling. tCho was significantly decreased in steatohepatitis (0.31 %, 0.19) compared with steatosis (0.49 %, 0.28) (P = 0.01) and in both compared with the histologically normal samples (1.61 %, 0.69) (P < 0.005) ( Figure 3C ). Furthermore, PtC/tCho was significantly lower in the steatotic (33.7 %, 16.8) and steatohepatitic animals (27.6 %, 3.68) compared with normal animals (45.5 %, 6.14) ( Figure 3D ). These findings are consistent with reports of low plasma PtC and high urinary choline oxidation products seen in 129S6 mice fed a HFD [10] .
Relationship between intrahepatic lipid and obesity in murine models
Mouse body weight plotted against the lipid/water percentage ( Figure 4A ) demonstrated that intrahepatic lipid increased exponentially with increasing mouse body weight at the time of culling (r 2 = 0.80, P < 0.0005). The lipid/water percentage was also compared with the 
DISCUSSION
The results of the present study demonstrate that metabolic profiling of intact liver tissue using 1 H MAS MRS combined with PLS-DA is a powerful technique for the discrimination of NAFLD in animal models, differentiating by genetic (strain and the Gena/263 mutation), environmental (dietary) and histological factors. In particular, the first evidence is presented of accurate discrimination of histologically defined steatosis and steatohepatitis using MRS of intact tissue.
1 H MAS MRS with PLS-DA also enables the separation and classification of different mouse strains on differing diets, despite normal histological appearances. Furthermore, it has been established that an exponential relationship exists between hepatic steatosis and obesity in these murine models.
In liver tissue, the 'total signal' MR spectra are dominated by water and lipid resonances. Such spectra allow the quantification of lipid, either in absolute terms or as a proportion of the total signal in the spectrum. This marker of hepatic steatosis is a quantitative objective linear variable which compares favourably with the semi-quantitative subjective histological assessment of steatosis ( Figure 4B ) [7] . This is an important observation as steatosis is a prerequisite for the development of steatohepatitis and consequent fibrotic liver disease. In HFD-fed mice, there was a progressive significant increase in the lipid/water percentage from normal through steatotic to steatohepatitic samples. This may represent increased uptake of fatty acids by the liver, decreased export or decreased catabolism [1] . Additionally, defective peripheral fatty acid uptake shunts more fatty acids to the liver [24] . Intrahepatic lipid increased exponentially with animal weight, suggesting that fatty acid uptake peripherally was maximized in these mice at a weight approaching 40 g. Thereafter, intrahepatic lipid accumulated in preference to peripheral uptake of fatty acids and deposition of TAG (triacylglycerol). Accumulated NEFAs (non-esterified fatty acids; 'free fatty acids') may be disposed of by esterification to TAGs and by fatty acid oxidation producing oxidative stress and initiating inflammation [25] . Although the traditional two-hit hypothesis proposed that the development of steatosis is followed by a second hit initiating inflammation [26] , recent work by Yamaguchi et al. [25] suggests that this model is now too simple, and that visible lipid deposition is less pathogenically relevant. Differential fatty acid partitioning between esterification, leading to the accumulation of visible fat and oxidation of the invisible NEFAs, is more relevant to the pathogenesis. The use of MRS techniques in the present study enables the determination of total lipid composition, which includes the assessment of the invisible hepatic NEFA component.
The relative decrease in PUFAs seen with increasing disease severity supports previous evidence that a decrease in PUFAs has been observed in the liver and blood of obese Zucker rats [9] and in the serum of human subjects with hepatic steatosis and steatohepatitis [27, 28] . A reduced PUFA/MUFA ratio has been considered to represent a surrogate marker of lipid peroxidation, associated with oxidative stress [9] . Depletion of long-chain PUFAs within the liver is thought to increase fatty acid and TAG synthesis by up-regulation of lipogenic genes via reduced down-regulation of SREBP1 (sterol-regulatory-element-binding protein 1), and to decrease fatty acid oxidation, including by a reduction in PPARα (peroxisome-proliferator-activated receptor α) activation [29] .
PtC is an essential phospholipid [30] , existing as a membrane-bound macromolecule giving rise to a broad resonance [31] within which the -N(CH 3 ) 3 functional group of TMAO and betaine (oxidation products of choline metabolism) are co-resonant [16] . Measurement of choline levels demonstrates a decrease in choline-containing products in the obese models, and in those animals with steatosis and steatohepatitis, compared with histologically normal controls. Importantly, tCho is significantly lower in steatohepatitis compared with simple steatosis. This is consistent with the observation that mice fed a choline-deficient diet develop hepatic steatosis and steatohepatitis [32] . However, increasing lipid, which dominates the spectrum, may also contribute to the reduction in tCho observed, by means of a dilution effect. Therefore the PtC resonance (also containing betaine and TMAO) was integrated in isolation and expressed as a ratio of the tCho region. PtC biosynthesis from choline and methionine is required for normal hepatic secretion of VLDL (very-low-density lipoprotein) [33] , and decreased PtC leads to accumulation of intracellular TAG [34] . Indeed, when comparing the PtC resonance with the tCho region, PtC is reduced in mice with hepatic steatosis and steatohepatitis compared with histologically normal livers. This is consistent with work on aqueous liver tissue extract in obese Zucker rats where there was a reduction in betaine at δ 3.26 compared with lean controls [9] while betaine has been shown to protect against alcoholic hepatic steatosis in experimental animals [35] .
As with any technique, there are limitations to this approach to studying NAFLD. Although 1 H MAS MRS allows the quantification of protons within functional groups of metabolites, it is not possible to directly quantify specific fatty acids, as this requires accurate measurement of fatty acyl chain length and the position and number of functional groups within the chain. Nevertheless, the extent of saturation or (poly)unsaturation is of biological and clinical relevance. The overlap of certain resonances (particularly small resonances near the larger lipid peaks) may reduce the accuracy of integration of those peaks. However, by dividing the spectra into small regions or 'buckets', quantification is objective and consistent. Curve-fitting software is used in the in vivo setting and enables quantification of small numbers of overlapping peaks. Newer approaches such as 'targeted profiling' may improve quantification of the multiple peaks found in complex tissue and biofluid samples in vitro [36] .
The present study has demonstrated that a small number of resonances contribute reliably to the differentiation of the cohorts studied. Despite low field strength and the presence of motion artefacts, tCho and a number of lipid resonances may be resolved in human liver in vivo [37] , raising the possibility that 1 H MAS MRS could provide discriminatory information in the context of NAFLD in vivo.
In conclusion, the present study has demonstrated the utility of 1 H MAS MRS of intact liver tissue in conjunction with multivariate modelling techniques for the investigation and classification of murine models of NAFLD on the basis of environmental, genetic and histopathological features. Class membership may be predicted with high accuracy and it is possible to distinguish reliably between samples, even where histological appearances are indistinguishable. PLS-DA enables the identification of biologically relevant metabolites contributing to the differences between models. Future studies may employ these techniques to screen the output of programmes generating murine models of NAFLD and other liver diseases. Greater subject numbers will facilitate the use of separate large training and test sets. High resolution 1 H MAS MRS data may be used to aid the interpretation of future non-invasive in vivo MRS studies. As the resolution of 1 H MR spectra from in vivo MR scanners improves, a combination with multivariate statistical analysis may allow detailed non-invasive assessment of hepatic disease in animals and humans. 
